Systemic intravenous abciximab: a novel treatment for acute central retinal artery occlusion?

E-ISSN： 1755-3768|96|1|e101-e102

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.96, Iss.1, 2018-02, pp. : e101-e102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapy of macular oedema: meta‐analysis

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 637-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 431-434

John Wiley & Sons Inc

Access to resources Recommend Favorite

The venous oxygen saturation predicts the visual prognosis after anti‐VEGF treatment of central retinal vein occlusion

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment outcome of switching from ranibizumab to aflibercept in patients with central retinal vein occlusion

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Membranous nephropathy and central retinal vein occlusion

NEPHROLOGY, Vol. 20, Iss. 9, 2015-09 ,pp. : 668-669

John Wiley & Sons Inc

Access to resources Recommend Favorite